$MDRX
Veradigm Inc. Stock $mdrx

$mdrx Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000095017022002112 Filed on February 25, 2022

Income Statement

Concept	2021 Q4	2021 Q3	2021
Revenue	$391.7M	$369.3M	$1.503B
YoY Change	1.37%	1.0%	0.02%
Cost Of Revenue	$222.7M	$220.5M	$883.5M
YoY Change	-1.19%	-4.33%	-5.71%
Gross Profit	$169.0M	$148.8M	$619.6M
YoY Change	4.95%	10.09%	9.52%
Gross Profit Margin	43.14%	40.29%	41.22%
Selling, General & Admin	$74.22M	$78.79M	$313.8M
YoY Change	-20.85%	-15.68%	-19.52%
% of Gross Profit	43.92%	52.96%	50.65%
Research & Development	$47.74M	$45.54M	$193.7M
YoY Change	-12.06%	-1.75%	-6.01%
% of Gross Profit	28.25%	30.61%	31.26%
Depreciation & Amortization	$43.15M	$44.28M	$176.1M
YoY Change	11.78%	-10.01%	-8.39%
% of Gross Profit	25.53%	29.76%	28.43%
Operating Expenses	$127.6M	$130.2M	$507.5M
YoY Change	-13.82%	-6.9%	-14.85%
Operating Profit	$41.39M	$12.10M	$77.20M
YoY Change	-160.8%	-208.45%	-158.98%
Interest Expense	-$1.379M	-$3.874M	$13.17M
YoY Change	-121.35%	-158.11%	-61.39%
% of Operating Profit	-3.33%	-32.01%	17.05%
Other Income/Expense, Net	$65.17M	$4.700M	$87.67M
YoY Change	724033.33%	1080.9%	162244.44%
Pretax Income	$105.2M	$21.30M	$161.8M
YoY Change	-240.71%	-217.68%	-208.38%
Income Tax	$17.90M	$5.099M	$27.85M
% Of Pretax Income	17.02%	23.94%	17.21%
Net Earnings	$87.28M	$16.18M	$134.4M
YoY Change	-88.01%	2885.24%	-80.81%
Net Earnings / Revenue	22.28%	4.38%	8.94%
Basic Earnings Per Share		$0.13	$1.03
Diluted Earnings Per Share	$679.8K	$0.12	$0.97
COMMON SHARES
Basic Shares Outstanding		123.9M	130.1M
Diluted Shares Outstanding		131.4M	138.7M

Balance Sheet

Concept	2021 Q4	2021 Q3	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$132.5M	$214.2M	$132.5M
YoY Change	-75.05%	-2.07%	-75.05%
Cash & Equivalents	$132.5M	$214.2M	$132.5M
Short-Term Investments
Other Short-Term Assets	$2.302M	$126.6M	$1.187B
YoY Change	-30.66%	-48.72%	731.77%
Inventory
Prepaid Expenses	$116.6M
Receivables	$171.6M	$464.2M	$235.1M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$761.3M	$805.0M	$1.554B
YoY Change	-33.98%	-15.16%	34.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.819M	$124.0M	$28.14M
YoY Change	-86.39%	77.02%	-83.33%
Goodwill	$506.6M	$974.4M
YoY Change	-48.03%	-24.3%
Intangibles	$201.7M	$52.00M
YoY Change	-40.43%	-86.35%
Long-Term Investments	$12.26M		$12.26M
YoY Change	14.11%		14.58%
Other Assets	$83.43M	$104.7M	$71.17M
YoY Change	-8.95%	-11.78%	-17.91%
Total Long-Term Assets	$1.664B	$1.679B	$870.7M
YoY Change	-5.7%	-23.58%	-50.65%
TOTAL ASSETS
Total Short-Term Assets	$761.3M	$805.0M	$1.554B
Total Long-Term Assets	$1.664B	$1.679B	$870.7M
Total Assets	$2.425B	$2.484B	$2.425B
YoY Change	-16.88%	-21.04%	-16.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.281M	$21.80M	$5.281M
YoY Change	-85.29%	-59.33%	-85.29%
Accrued Expenses	$54.52M	$205.5M	$91.71M
YoY Change	-45.62%	-28.13%	-54.94%
Deferred Revenue	$120.7M
YoY Change	-63.93%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$547.1M	$566.9M	$598.0M
YoY Change	-41.47%	-23.87%	-36.03%
LONG-TERM LIABILITIES
Long-Term Debt	$350.1M	$373.2M	$350.1M
YoY Change	108.88%	-63.63%	108.87%
Other Long-Term Liabilities	$33.82M	$109.1M	$52.42M
YoY Change	-0.2%	238.71%	-59.93%
Total Long-Term Liabilities	$383.9M	$482.3M	$402.5M
YoY Change	90.53%	-54.43%	34.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$547.1M	$566.9M	$598.0M
Total Long-Term Liabilities	$383.9M	$482.3M	$402.5M
Total Liabilities	$1.017B	$1.066B	$1.017B
YoY Change	-18.72%	-45.01%	-18.72%
SHAREHOLDERS EQUITY
Retained Earnings	$767.6M
YoY Change	21.23%
Common Stock	$1.965B
YoY Change	3.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.322B
YoY Change	51.83%
Treasury Stock Shares	$160.6M
Shareholders Equity	$1.408B	$1.419B	$1.408B
YoY Change
Total Liabilities & Shareholders Equity	$2.425B	$2.484B	$2.425B
YoY Change	-16.88%	-21.04%	-16.88%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2021
OPERATING ACTIVITIES
Net Income	$87.28M	$16.18M	$134.4M
YoY Change	-88.01%	2885.24%	-80.81%
Depreciation, Depletion And Amortization	$43.15M	$44.28M	$176.1M
YoY Change	11.78%	-10.01%	-8.39%
Cash From Operating Activities	$65.04M	$55.89M	-$75.43M
YoY Change	-136.42%	5.45%	-29.32%
INVESTING ACTIVITIES
Capital Expenditures	-$18.53M	-$21.47M	$5.295M
YoY Change	-3.0%	-16.79%	-68.9%
Acquisitions			$0.00
YoY Change
Other Investing Activities	$61.23M	$1.139M	$0.00
YoY Change	-96.4%	-28.81%
Cash From Investing Activities	$42.70M	-$20.33M	-$12.18M
YoY Change	-97.46%	-16.0%	-100.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$417.4M
YoY Change			24.66%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-133.5M	-50.08M	-258.9M
YoY Change	-88.78%	427.16%	-76.67%
NET CHANGE
Cash From Operating Activities	65.04M	55.89M	-75.43M
Cash From Investing Activities	42.70M	-20.33M	-12.18M
Cash From Financing Activities	-133.5M	-50.08M	-258.9M
Net Change In Cash	-25.80M	-14.52M	-346.9M
YoY Change	-108.29%	-175.22%	-186.75%
FREE CASH FLOW
Cash From Operating Activities	$65.04M	$55.89M	-$75.43M
Capital Expenditures	-$18.53M	-$21.47M	$5.295M
Free Cash Flow	$83.57M	$77.36M	-$80.72M
YoY Change	-152.4%	-1.83%	-34.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	36-4392754
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60654
CY2021	dei	Entity File Number EntityFileNumber	001-35547
CY2021	dei	Entity Registrant Name EntityRegistrantName	ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001124804
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	222 Merchandise Mart Plaza
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2024
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Chicago
CY2021	dei	City Area Code CityAreaCode	800
CY2021	dei	Local Phone Number LocalPhoneNumber	334-8534
CY2021	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2021	dei	Trading Symbol TradingSymbol	MDRX
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	2251974226
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	116208603
CY2021	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	118942000
CY2021	dei	Auditor Location AuditorLocation	Raleigh, North Carolina
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	188351000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	531104000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2169000
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	6361000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	29943000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	31596000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	327069000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	347355000
CY2021Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	1068000
CY2020Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	1068000
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	124811000
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	106717000
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	25421000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	136264000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	761342000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	1153222000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47902000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	72162000
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	172104000
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	193202000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	235930000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	286602000
CY2021Q4	us-gaap	Goodwill Goodwill	974478000
CY2020Q4	us-gaap	Goodwill Goodwill	974729000
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6607000
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5790000
CY2021Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Noncurrent ContractWithCustomerAssetAccumulatedAllowanceForCreditLossNoncurrent	2273000
CY2020Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Noncurrent ContractWithCustomerAssetAccumulatedAllowanceForCreditLossNoncurrent	4273000
CY2021Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	56797000
CY2020Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	43682000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	68909000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	96601000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	101160000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	91628000
CY2021Q4	us-gaap	Assets Assets	2425229000
CY2020Q4	us-gaap	Assets Assets	2917618000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16836000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	35905000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92525000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100262000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	92222000
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	118771000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	325900000
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	334764000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19599000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22264000
CY2021Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	322811000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	547082000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	934777000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	350062000
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	167587000
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	4407000
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	3471000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	16625000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18186000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	64822000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	93463000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34093000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	33891000
CY2021Q4	us-gaap	Liabilities Liabilities	1017091000
CY2020Q4	us-gaap	Liabilities Liabilities	1251375000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	349000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	349000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	276705000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	116114000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	274558000
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139942000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2766000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	2745000
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	160591000
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	134616000
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1321805000
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	870558000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1962386000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1902776000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1632611000
CY2021	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	118700000
CY2020	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	118399000
CY2019	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	107874000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	883472000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	937005000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	767556000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	633118000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2765000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1838000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1408138000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1666243000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2425229000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2917618000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1503037000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1502700000
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	1022324000
CY2021	us-gaap	Gross Profit GrossProfit	619565000
CY2020	us-gaap	Gross Profit GrossProfit	565695000
CY2019	us-gaap	Gross Profit GrossProfit	610287000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	313814000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	389941000
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	400808000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	193671000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	206061000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	245443000
CY2021	mdrx	Asset Impairment Charges Excluding Goodwill Impairment AssetImpairmentChargesExcludingGoodwillImpairment	11772000
CY2020	mdrx	Asset Impairment Charges Excluding Goodwill Impairment AssetImpairmentChargesExcludingGoodwillImpairment	74969000
CY2019	mdrx	Asset Impairment Charges Excluding Goodwill Impairment AssetImpairmentChargesExcludingGoodwillImpairment	10837000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	25700000
CY2021	mdrx	Amortization Of Intangible And Acquisition Related Assets AmortizationOfIntangibleAndAcquisitionRelatedAssets	23109000
CY2020	mdrx	Amortization Of Intangible And Acquisition Related Assets AmortizationOfIntangibleAndAcquisitionRelatedAssets	25604000
CY2019	mdrx	Amortization Of Intangible And Acquisition Related Assets AmortizationOfIntangibleAndAcquisitionRelatedAssets	27188000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	77199000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-130880000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-99689000
CY2021	us-gaap	Interest Expense InterestExpense	13166000
CY2020	us-gaap	Interest Expense InterestExpense	34104000
CY2019	us-gaap	Interest Expense InterestExpense	43172000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	87666000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	54000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-138904000
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	8370000
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	1575000
CY2019	us-gaap	Impairment Of Investments ImpairmentOfInvestments	651000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1757000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	17194000
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	665000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	161826000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-149311000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-281751000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27851000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16692000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-43340000
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	133975000
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-132619000
CY2019	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-238411000
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-15000
CY2020	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	71448000
CY2019	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	75235000
CY2021	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	647000
CY2020	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	1156504000
CY2019	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0
CY2021	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	169000
CY2020	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	394926000
CY2019	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	19426000
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	463000
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	833026000
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	55809000
CY2021	us-gaap	Profit Loss ProfitLoss	134438000
CY2020	us-gaap	Profit Loss ProfitLoss	700407000
CY2019	us-gaap	Profit Loss ProfitLoss	-182602000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-424000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	134438000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	700407000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-182178000
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.03
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.83
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.43
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	5.23
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.33
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.40
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.10
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.97
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.83
CY2019	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.43
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	5.23
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.33
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.97
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.40
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.10
CY2021	us-gaap	Profit Loss ProfitLoss	134438000
CY2020	us-gaap	Profit Loss ProfitLoss	700407000
CY2019	us-gaap	Profit Loss ProfitLoss	-182602000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-69000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	1435000
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	1192000
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax	-1157000
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax	1509000
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax	-262000
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-1226000
CY2020	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	2944000
CY2019	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	930000
CY2021	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-299000
CY2020	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	390000
CY2019	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-67000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-927000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2554000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	997000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	133511000
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	702961000
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-181605000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-424000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	133511000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	702961000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-181181000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1666243000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1285188000
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1580427000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1408138000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1666243000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1285188000
CY2021	us-gaap	Profit Loss ProfitLoss	134438000
CY2020	us-gaap	Profit Loss ProfitLoss	700407000
CY2019	us-gaap	Profit Loss ProfitLoss	-182602000
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	463000
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	833026000
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	55809000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	34036000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	38982000
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	2099000
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	3275000
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	37970000
CY2021	mdrx	Impairment Of Assets And Long Term Investments ImpairmentOfAssetsAndLongTermInvestments	11772000
CY2020	mdrx	Impairment Of Assets And Long Term Investments ImpairmentOfAssetsAndLongTermInvestments	76544000
CY2019	mdrx	Impairment Of Assets And Long Term Investments ImpairmentOfAssetsAndLongTermInvestments	37188000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1757000
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	133975000
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-132619000
CY2019	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-238411000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	176137000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	192269000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	198226000
CY2021	mdrx	Non Cash Operating Lease Expense NonCashOperatingLeaseExpense	-3859000
CY2020	mdrx	Non Cash Operating Lease Expense NonCashOperatingLeaseExpense	1454000
CY2019	mdrx	Non Cash Operating Lease Expense NonCashOperatingLeaseExpense	-2588000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	35169000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	17194000
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	665000
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	8370000
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	69141000
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	5900000
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-10042000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5002000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-35163000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9430000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-17794000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	34418000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	16251000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-18729000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-66987000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	27552000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	21971000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3064000
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3894000
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-26034000
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	49492000
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-32764000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-13692000
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	28667000
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-92067000
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	205000
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	5334000
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-7555000
CY2021	mdrx	Increase Decrease In Accrued Us Department Of Justice Settlement IncreaseDecreaseInAccruedUSDepartmentOfJusticeSettlement	0
CY2020	mdrx	Increase Decrease In Accrued Us Department Of Justice Settlement IncreaseDecreaseInAccruedUSDepartmentOfJusticeSettlement	-147169000
CY2019	mdrx	Increase Decrease In Accrued Us Department Of Justice Settlement IncreaseDecreaseInAccruedUSDepartmentOfJusticeSettlement	145000000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	248340000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	12333000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	15395000
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-323768000
CY2020	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-119048000
CY2019	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	30859000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-75428000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-106715000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	46254000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5295000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17025000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16450000
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	73265000
CY2020	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	87993000
CY2019	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	103317000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	23443000
CY2021	mdrx	Proceeds From Divestiture Of Businesses And Other Investments Net Of Cash Divested And Distributions Received ProceedsFromDivestitureOfBusinessesAndOtherInvestmentsNetOfCashDivestedAndDistributionsReceived	68806000
CY2020	mdrx	Proceeds From Divestiture Of Businesses And Other Investments Net Of Cash Divested And Distributions Received ProceedsFromDivestitureOfBusinessesAndOtherInvestmentsNetOfCashDivestedAndDistributionsReceived	1734967000
CY2019	mdrx	Proceeds From Divestiture Of Businesses And Other Investments Net Of Cash Divested And Distributions Received ProceedsFromDivestitureOfBusinessesAndOtherInvestmentsNetOfCashDivestedAndDistributionsReceived	1044000
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2421000
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	7097000
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	8235000
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-14000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-12175000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	1622852000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-150387000
CY2021	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0
CY2020	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-7664000
CY2019	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-10669000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12175000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1615188000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-161056000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	14023000
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6033000
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7286000
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	218000000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	758000
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5445000
CY2021	mdrx	Payments For Capped Call Transactions PaymentsForCappedCallTransactions	0
CY2020	mdrx	Payments For Capped Call Transactions PaymentsForCappedCallTransactions	0
CY2019	mdrx	Payments For Capped Call Transactions PaymentsForCappedCallTransactions	17222000
CY2021	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0
CY2020	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	352361000
CY2019	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	75000000
CY2020	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1315000000
CY2019	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	220000000
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	250000000
CY2020	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	903625000
CY2019	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	279241000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	417443000
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	334863000
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	111460000
CY2021	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	2400000
CY2020	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	4369000
CY2019	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	14685000
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0
CY2019	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	53800000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-258866000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1109759000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	67343000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-476000
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1212000
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	203000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-346945000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	399926000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47256000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	537465000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	137539000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	184795000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	190520000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	537465000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	137539000
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of consolidated financial statements in accordance with generally accepted accounting principles in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and the accompanying notes. Our estimates and assumptions consider the economic implications of COVID-19 on our critical and significant accounting estimates. Actual results could differ materially from these estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	338677000
CY2020Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	327519000
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	166573000
CY2020Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	134317000
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	172104000
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	193202000
CY2021	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	73265000
CY2020	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	87993000
CY2019	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	103317000
CY2021	mdrx	Capitalized Computer Software Written Off Related To Sale Of Business Unit CapitalizedComputerSoftwareWrittenOffRelatedToSaleOfBusinessUnit	3105000
CY2020	mdrx	Capitalized Computer Software Written Off Related To Sale Of Business Unit CapitalizedComputerSoftwareWrittenOffRelatedToSaleOfBusinessUnit	31214000
CY2019	mdrx	Capitalized Computer Software Written Off Related To Sale Of Business Unit CapitalizedComputerSoftwareWrittenOffRelatedToSaleOfBusinessUnit	0
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	91258000
CY2020	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	86269000
CY2019	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	72840000
CY2020Q1	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	216580000
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	19511000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	21143000
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	23998000
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentrations of Credit Risk</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject us to a concentration of credit risk consist of cash, cash equivalents, marketable securities and trade receivables. We primarily maintain our cash balances with one major commercial bank domestically and several commercial banks internationally.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We sell our products and services to healthcare providers. Credit risk with respect to trade receivables is generally diversified due to the large number of clients and their geographic dispersion. To reduce credit risk, we perform ongoing credit evaluations of significant clients and their payment histories. In general, we do not require collateral from our clients, but we do enter into advance deposit agreements, if appropriate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The majority of our revenue is derived from clients located in the United States. The majority of long-lived assets are also located in the United States. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the years ended December 31, 2021 and 2020, we had one client that accounted for 12.5% and 12%, respectively, of our revenue. Other than this one client, no single client accounted for more than 10% of our revenue in the years ended December 31, 2021, 2020 and 2019.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">No client represented more than 10% of accounts receivable as of December 31, 2021 and 2020.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"/></span></p>
CY2021	us-gaap	Segment Reporting Disclosure Of Major Customers SegmentReportingDisclosureOfMajorCustomers	For the years ended December 31, 2021 and 2020, we had one client that accounted for 12.5% and 12%, respectively, of our revenue. Other than this one client, no single client accounted for more than 10% of our revenue in the years ended December 31, 2021, 2020 and 2019.
CY2021	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	No client represented more than 10% of accounts receivable as of December 31, 2021 and 2020.
CY2021	mdrx	Number Of Revenue Streams NumberOfRevenueStreams	2
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	137848000
CY2021Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	151857000
CY2021Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	144696000
CY2021Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	151763000
CY2021Q1	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	173316000
CY2021Q2	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	158910000
CY2021Q3	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	159149000
CY2021Q4	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	171345000
CY2021Q1	mdrx	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Right To Invoice Expedient ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueRightToInvoiceExpedient	56811000
CY2021Q2	mdrx	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Right To Invoice Expedient ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueRightToInvoiceExpedient	62422000
CY2021Q3	mdrx	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Right To Invoice Expedient ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueRightToInvoiceExpedient	64820000
CY2021Q4	mdrx	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Right To Invoice Expedient ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueRightToInvoiceExpedient	68089000
CY2021Q1	mdrx	Reimbursed Travel Expenses Shipping And Other Revenue ReimbursedTravelExpensesShippingAndOtherRevenue	377000
CY2021Q2	mdrx	Reimbursed Travel Expenses Shipping And Other Revenue ReimbursedTravelExpensesShippingAndOtherRevenue	525000
CY2021Q3	mdrx	Reimbursed Travel Expenses Shipping And Other Revenue ReimbursedTravelExpensesShippingAndOtherRevenue	607000
CY2021Q4	mdrx	Reimbursed Travel Expenses Shipping And Other Revenue ReimbursedTravelExpensesShippingAndOtherRevenue	502000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	368352000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	373714000
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	369272000
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	391699000
CY2020Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	105366000
CY2020Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	119545000
CY2020Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	118300000
CY2020Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	138279000
CY2019Q3	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	227954000
CY2020Q2	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	195308000
CY2020Q3	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	192658000
CY2020Q4	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	182690000
CY2020Q1	mdrx	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Right To Invoice Expedient ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueRightToInvoiceExpedient	58059000
CY2020Q2	mdrx	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Right To Invoice Expedient ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueRightToInvoiceExpedient	54082000
CY2020Q3	mdrx	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Right To Invoice Expedient ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueRightToInvoiceExpedient	54313000
CY2020Q4	mdrx	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Right To Invoice Expedient ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueRightToInvoiceExpedient	65108000
CY2020Q1	mdrx	Reimbursed Travel Expenses Shipping And Other Revenue ReimbursedTravelExpensesShippingAndOtherRevenue	1359000
CY2020Q2	mdrx	Reimbursed Travel Expenses Shipping And Other Revenue ReimbursedTravelExpensesShippingAndOtherRevenue	369000
CY2020Q3	mdrx	Reimbursed Travel Expenses Shipping And Other Revenue ReimbursedTravelExpensesShippingAndOtherRevenue	347000
CY2020Q4	mdrx	Reimbursed Travel Expenses Shipping And Other Revenue ReimbursedTravelExpensesShippingAndOtherRevenue	337000
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	381364000
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	369304000
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	365618000
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	386414000
CY2019Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	93602000
CY2019Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	113288000
CY2019Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	116812000
CY2019Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	136460000
CY2019Q1	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	248126000
CY2019Q2	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	233293000
CY2019Q4	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	214952000
CY2019Q1	mdrx	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Right To Invoice Expedient ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueRightToInvoiceExpedient	55923000
CY2019Q2	mdrx	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Right To Invoice Expedient ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueRightToInvoiceExpedient	62245000
CY2019Q3	mdrx	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Right To Invoice Expedient ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueRightToInvoiceExpedient	61814000
CY2019Q4	mdrx	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Right To Invoice Expedient ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueRightToInvoiceExpedient	60826000
CY2019Q1	mdrx	Reimbursed Travel Expenses Shipping And Other Revenue ReimbursedTravelExpensesShippingAndOtherRevenue	1467000
CY2019Q2	mdrx	Reimbursed Travel Expenses Shipping And Other Revenue ReimbursedTravelExpensesShippingAndOtherRevenue	2057000
CY2019Q3	mdrx	Reimbursed Travel Expenses Shipping And Other Revenue ReimbursedTravelExpensesShippingAndOtherRevenue	1700000
CY2019Q4	mdrx	Reimbursed Travel Expenses Shipping And Other Revenue ReimbursedTravelExpensesShippingAndOtherRevenue	2092000
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	399118000
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	410883000
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	408280000
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	414330000
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3800000000
CY2021Q4	mdrx	Revenue Remaining Performance Obligation Percentage Year One RevenueRemainingPerformanceObligationPercentageYearOne	0.34
CY2021Q4	mdrx	Revenue Remaining Performance Obligation Percentage After Year One RevenueRemainingPerformanceObligationPercentageAfterYearOne	0.66
CY2020	mdrx	Recurring Revenue RecurringRevenue	1222731000
CY2019	mdrx	Recurring Revenue RecurringRevenue	1278456000
CY2021	mdrx	Non Recurring Revenue NonRecurringRevenue	293291000
CY2020	mdrx	Non Recurring Revenue NonRecurringRevenue	279969000
CY2021Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Noncurrent ContractWithCustomerAssetAccumulatedAllowanceForCreditLossNoncurrent	2273000
CY2019	mdrx	Non Recurring Revenue NonRecurringRevenue	354155000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1503037000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1502700000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1632611000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1503037000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1502700000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1632611000
CY2021	mdrx	Recurring Revenue RecurringRevenue	1209746000
CY2020Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	5341000
CY2019Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	5341000
CY2021	us-gaap	Contract With Customer Asset Allowance For Credit Loss Period Increase Decrease ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease	-2000000
CY2020	us-gaap	Contract With Customer Asset Allowance For Credit Loss Period Increase Decrease ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease	0
CY2021Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	3341000
CY2020Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	5341000
CY2021Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	1068000
CY2020Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	1068000
CY2020Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Noncurrent ContractWithCustomerAssetAccumulatedAllowanceForCreditLossNoncurrent	4273000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	22343000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	25394000
CY2021	us-gaap	Sublease Income SubleaseIncome	314000
CY2020	us-gaap	Sublease Income SubleaseIncome	1121000
CY2021	us-gaap	Lease Cost LeaseCost	22029000
CY2020	us-gaap	Lease Cost LeaseCost	24273000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	24141000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	26638000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3252000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	21770000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	68909000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	96601000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19599000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22264000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	64822000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	93463000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.033
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.036
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22093000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	20285000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	14805000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	13438000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	12105000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	8655000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	91381000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6960000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19599000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	64822000
CY2021	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2020-07-01
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	352000
CY2019Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1509000
CY2021	mdrx	Number Of Equity Method Investments NumberOfEquityMethodInvestments	4
CY2021Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	7099000
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	12260000
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	10744000
CY2021	mdrx	Number Of Cost With Adjustments NumberOfCostWithAdjustments	7
CY2021Q4	mdrx	Cost Method Investment With Adjustments Original Cost CostMethodInvestmentWithAdjustmentsOriginalCost	57213000
CY2021Q4	mdrx	Cost Method Investment Net Of Cost With Adjustments Carrying Value CostMethodInvestmentNetOfCostWithAdjustmentsCarryingValue	49293000
CY2020Q4	mdrx	Cost Method Investment Net Of Cost With Adjustments Carrying Value CostMethodInvestmentNetOfCostWithAdjustmentsCarryingValue	25059000
CY2021	mdrx	Number Of Equity Method Investments And Cost Less Impairment NumberOfEquityMethodInvestmentsAndCostLessImpairment	11
CY2021Q4	mdrx	Equity Method Investments Cost Less Impairment Original Cost EquityMethodInvestmentsCostLessImpairmentOriginalCost	64312000
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	61553000
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	35803000
CY2021Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	475000
CY2020	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	16800000
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	370860000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	396135000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	322958000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	323973000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47902000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	72162000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	26847000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	32324000
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	46705000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1209097000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1025167000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	183930000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1209428000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	974826000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	234602000
CY2021Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	52000000
CY2020Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	52000000
CY2021Q4	us-gaap	Goodwill Goodwill	974478000
CY2020Q4	us-gaap	Goodwill Goodwill	974729000
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1026478000
CY2020Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1026729000
CY2020Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0
CY2021Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0
CY2019Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	39200000
CY2019Q4	us-gaap	Goodwill Goodwill	974110000
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	619000
CY2020Q4	us-gaap	Goodwill Goodwill	974729000
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-251000
CY2021Q4	us-gaap	Goodwill Goodwill	974478000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50552000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57734000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62222000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	44117000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	27905000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	23765000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	20177000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	16521000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	51445000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	183930000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	11800000
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	1600000
CY2019	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	2700000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	11772000
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	74969000
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10837000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	25700000
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	1575000
CY2019	us-gaap	Impairment Of Investments ImpairmentOfInvestments	651000
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	342853000
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-7209000
CY2021Q4	mdrx	Long Term Debt Paid Off Costs LongTermDebtPaidOffCosts	350062000
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	167853000
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	266000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	175000000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0
CY2020Q4	mdrx	Long Term Debt Paid Off Costs LongTermDebtPaidOffCosts	167587000
CY2021Q4	mdrx	Maximum Foreign Subsidiary Capital Stock Percentage As Guarantee MaximumForeignSubsidiaryCapitalStockPercentageAsGuarantee	0.65
CY2021Q4	mdrx	Debt Instrument Face Amount Including Equity Accretion DebtInstrumentFaceAmountIncludingEquityAccretion	382911000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-930000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-38353000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27851000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16692000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-43340000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	207911000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	141367000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-148174000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-287088000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	20459000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1137000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	5337000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	161826000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-149311000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-281751000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	17179000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-19346000
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-8232000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	507000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-219000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-1809000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	7998000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3803000
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	5054000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	25684000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-15762000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-4987000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3341000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2931000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-28732000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-34000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2981000
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-8763000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1140000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-880000
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-858000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2167000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	33983000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-31355000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-59170000
CY2021	mdrx	Income Tax Reconciliation Nondeductible Expense Restructuring Charges Reversals IncomeTaxReconciliationNondeductibleExpenseRestructuringChargesReversals	0
CY2020	mdrx	Income Tax Reconciliation Nondeductible Expense Restructuring Charges Reversals IncomeTaxReconciliationNondeductibleExpenseRestructuringChargesReversals	0
CY2019	mdrx	Income Tax Reconciliation Nondeductible Expense Restructuring Charges Reversals IncomeTaxReconciliationNondeductibleExpenseRestructuringChargesReversals	31000
CY2021	mdrx	Income Tax Reconciliation Nondeductible Expense Department Of Justice Settlement IncomeTaxReconciliationNondeductibleExpenseDepartmentOfJusticeSettlement	-1050000
CY2020	mdrx	Income Tax Reconciliation Nondeductible Expense Department Of Justice Settlement IncomeTaxReconciliationNondeductibleExpenseDepartmentOfJusticeSettlement	0
CY2019	mdrx	Income Tax Reconciliation Nondeductible Expense Department Of Justice Settlement IncomeTaxReconciliationNondeductibleExpenseDepartmentOfJusticeSettlement	18546000
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	5000000
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	6500000
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	6126000
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies Domestic IncomeTaxReconciliationTaxContingenciesDomestic	2007000
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies Domestic IncomeTaxReconciliationTaxContingenciesDomestic	3204000
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies Domestic IncomeTaxReconciliationTaxContingenciesDomestic	1046000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	7161000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2940000
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-7411000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1103000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	5314000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	4664000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	7000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	118000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	549000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	2579000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1443000
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	3079000
CY2021	mdrx	Income Tax Reconciliation Provision To Return Adjustments IncomeTaxReconciliationProvisionToReturnAdjustments	-9544000
CY2020	mdrx	Income Tax Reconciliation Provision To Return Adjustments IncomeTaxReconciliationProvisionToReturnAdjustments	-2362000
CY2019	mdrx	Income Tax Reconciliation Provision To Return Adjustments IncomeTaxReconciliationProvisionToReturnAdjustments	-383000
CY2021	mdrx	Income Tax Rate Reconciliation Deductions Dividend Deemed To Be Received From Subsidiaries IncomeTaxRateReconciliationDeductionsDividendDeemedToBeReceivedFromSubsidiaries	-208000
CY2020	mdrx	Income Tax Rate Reconciliation Deductions Dividend Deemed To Be Received From Subsidiaries IncomeTaxRateReconciliationDeductionsDividendDeemedToBeReceivedFromSubsidiaries	-352000
CY2019	mdrx	Income Tax Rate Reconciliation Deductions Dividend Deemed To Be Received From Subsidiaries IncomeTaxRateReconciliationDeductionsDividendDeemedToBeReceivedFromSubsidiaries	-473000
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0
CY2019	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-630000
CY2021	mdrx	Income Tax Reconciliation Tax Reform Impact IncomeTaxReconciliationTaxReformImpact	0
CY2020	mdrx	Income Tax Reconciliation Tax Reform Impact IncomeTaxReconciliationTaxReformImpact	0
CY2019	mdrx	Income Tax Reconciliation Tax Reform Impact IncomeTaxReconciliationTaxReformImpact	2972000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	5397000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	66000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	28000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	43000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1504000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	16949000
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	922000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	41000
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-943000
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1398000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27851000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16692000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-43340000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	11689000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	18260000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	8750000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	9571000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	9869000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8428000
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	42672000
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	35016000
CY2021Q4	mdrx	Deferred Tax Assets Operating And Finance Lease Liabilities DeferredTaxAssetsOperatingAndFinanceLeaseLiabilities	15612000
CY2020Q4	mdrx	Deferred Tax Assets Operating And Finance Lease Liabilities DeferredTaxAssetsOperatingAndFinanceLeaseLiabilities	22902000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	33231000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	35695000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	432000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	251000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4519000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	34339000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35491000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	87916000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	99151000
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	4272000
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	4329000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	88000
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2062000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	80273000
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	86841000
CY2021Q4	mdrx	Deferred Tax Liabilities Operating And Finance Right Of Use Assets DeferredTaxLiabilitiesOperatingAndFinanceRightOfUseAssets	11840000
CY2020Q4	mdrx	Deferred Tax Liabilities Operating And Finance Right Of Use Assets DeferredTaxLiabilitiesOperatingAndFinanceRightOfUseAssets	18315000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-1461000
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	97934000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	111547000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	10018000
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	12396000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20604000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	19821000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1000000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	8053000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1240000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	276000
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6607000
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5790000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	16625000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18186000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	10018000
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	12396000
CY2021	mdrx	Net Operating Loss Carryforwards Beginning Expiration Year NetOperatingLossCarryforwardsBeginningExpirationYear	2031
CY2017	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	400000
CY2017	mdrx	Increase Decrease Diluted Earnings Per Share IncreaseDecreaseDilutedEarningsPerShare	0.01
CY2021	mdrx	Income Tax Partial Tax Holiday Period IncomeTaxPartialTaxHolidayPeriod	P5Y
CY2021	mdrx	Income Tax Holiday Tax Savings Impact IncomeTaxHolidayTaxSavingsImpact	300000
CY2021	mdrx	Increase Decrease Diluted Earnings Per Share IncreaseDecreaseDilutedEarningsPerShare	0.01
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	28885000
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	685000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	427000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	95000
CY2021	mdrx	Unrecognized Tax Benefits Increase Decrease Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromForeignCurrencyTranslation	0
CY2020	mdrx	Unrecognized Tax Benefits Increase Decrease Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromForeignCurrencyTranslation	2000
CY2019	mdrx	Unrecognized Tax Benefits Increase Decrease Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromForeignCurrencyTranslation	3000
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	201000
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	555000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	30294000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	28885000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20604000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	30300000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	28900000
CY2021	mdrx	Estimated Increase In Income Tax Expense Benefit EstimatedIncreaseInIncomeTaxExpenseBenefit	33500000
CY2020	mdrx	Estimated Increase In Income Tax Expense Benefit EstimatedIncreaseInIncomeTaxExpenseBenefit	30800000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	32218000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	29793000
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1332000
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.69
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	3200000
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	2000000.0
CY2021Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	18200000
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-1172000
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-1620000
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-229000
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	3220000
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	2048000
CY2021	mdrx	Cumulative Operating Income Loss Period CumulativeOperatingIncomeLossPeriod	P3Y
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	43563000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38890000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42690000
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4900000
CY2021	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0
CY2020	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0
CY2019	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	58800000
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2021	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	904000
CY2020	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	808000
CY2019	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	705000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	29045000
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-424000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
CY2021	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	133975000
CY2020	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-132619000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1332000
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	13.69
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	98000
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	14.01
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1234000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.67
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1234000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	13.67
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1234000
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	13.67
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.00
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.00
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.00
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.00
CY2021	mdrx	Stock Options Exercisable Period StockOptionsExercisablePeriod	P7Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	133975000
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-132619000
CY2019	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-238411000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0
CY2019	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-237987000
CY2021	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	463000
CY2020	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	833026000
CY2019	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	55809000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	134438000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	700407000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-182178000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130140000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	159281000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	166306000
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.03
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.83
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.43
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	5.23
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.33
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.40
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.10
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	133975000
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-132619000
CY2019	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-238411000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-424000
CY2021	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	133975000
CY2020	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-132619000
CY2019	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-237987000
CY2021	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	463000
CY2020	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	833026000
CY2019	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	55809000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	134438000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	700407000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-182178000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130140000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	159281000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	166306000
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8518000
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	138658000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159281000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	166306000
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.97
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.83
CY2019	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.43
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	5.23
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.33
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.97
CY2020	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	3022000
CY2020	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	468000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2554000
CY2021	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	282000
CY2021	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	1209000
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.40
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.10
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	42845000
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27945000
CY2019	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	1253000
CY2019	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	256000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	997000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-927000
CY2020Q4	us-gaap	Aoci Tax Attributable To Parent AociTaxAttributableToParent	390000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-69000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-69000
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-1226000
CY2021	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	299000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-927000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	1435000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1435000
CY2020	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	2944000
CY2020	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-390000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2554000
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	1192000
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1192000
CY2019	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	930000
CY2019	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	67000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	997000
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1509000
CY2019	us-gaap	Gross Profit GrossProfit	610287000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	77199000
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	352000
CY2021	us-gaap	Gross Profit GrossProfit	619565000
CY2020	us-gaap	Gross Profit GrossProfit	565695000
CY2021	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0
CY2020	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	101000
CY2019	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	769000
CY2020Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1503037000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1502700000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1632611000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-130880000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-99689000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190520000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	188351000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	531104000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2169000
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	6361000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	537465000
CY2021	us-gaap	Interest Paid InterestPaid	4993000
CY2020	us-gaap	Interest Paid InterestPaid	24616000
CY2019	us-gaap	Interest Paid InterestPaid	23917000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	330473000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	76595000
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	42972000
CY2021	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	534000
CY2020	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	752000
CY2019	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	701000
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	39146000
CY2020Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	37841000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	53379000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	62421000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92525000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100262000
CY2021Q4	mdrx	Maximum Percentage Accounted By Individual Item Of Current Liabilities MaximumPercentageAccountedByIndividualItemOfCurrentLiabilities	0.05
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	116640000
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	132944000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2302000
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3320000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	118942000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	136264000
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	0
CY2020Q4	us-gaap	Deferred Costs DeferredCosts	11025000
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	27031000
CY2020Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	27882000
CY2021Q4	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	61553000
CY2020Q4	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	35805000
CY2021Q4	mdrx	Deposit Assets And Other Assets Noncurrent DepositAssetsAndOtherAssetsNoncurrent	12576000
CY2020Q4	mdrx	Deposit Assets And Other Assets Noncurrent DepositAssetsAndOtherAssetsNoncurrent	16916000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	101160000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	91628000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1503037000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1502700000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1632611000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47902000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	72162000
CY2021	dei	Auditor Firm AuditorFirmId	248
CY2018Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	25826000
CY2019	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	3467000
CY2019	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	7288000
CY2019Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	22005000

Files In Submission

Name	View Source	Status
0000950170-22-002112-index-headers.html	Edgar Link	pending
0000950170-22-002112-index.html	Edgar Link	pending
0000950170-22-002112.txt	Edgar Link	pending
0000950170-22-002112-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
img213661804_0.jpg	Edgar Link	pending
mdrx-20211231.htm	Edgar Link	pending
mdrx-20211231.xsd	Edgar Link	pending
mdrx-20211231_cal.xml	Edgar Link	unprocessable
mdrx-20211231_def.xml	Edgar Link	unprocessable
mdrx-20211231_htm.xml	Edgar Link	completed
mdrx-20211231_lab.xml	Edgar Link	unprocessable
mdrx-20211231_pre.xml	Edgar Link	unprocessable
mdrx-ex10_20.htm	Edgar Link	pending
mdrx-ex10_28.htm	Edgar Link	pending
mdrx-ex10_29.htm	Edgar Link	pending
mdrx-ex21_1.htm	Edgar Link	pending
mdrx-ex23_1.htm	Edgar Link	pending
mdrx-ex31_1.htm	Edgar Link	pending
mdrx-ex31_2.htm	Edgar Link	pending
mdrx-ex32_1.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDRX
Veradigm Inc. Stock $mdrx

2021 Q4 Form 10-K Financial Statement

#000095017022002112 Filed on February 25, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDRX Veradigm Inc. Stock $mdrx

2021 Q4 Form 10-K Financial Statement

#000095017022002112 Filed on February 25, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDRX
Veradigm Inc. Stock $mdrx